Medical Diagnostics

Lucira Health

Brief Description Lucira Health is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Formerly known as Diassess, Inc.

Lucira Health had an initial public offering on the Nasdaq stock exchange under the ticker symbol of LHDX...

Kryptos Biotechnologies

Brief Description

Developer of molecular diagnostic software designed for the diagnosis of infectious diseases. The company's platform develops a point-of-care, ultrafast photonic polymerase chain reaction that can create a fast photothermal heating plasmonic thin film by a light-emitting diode, enabling medical professionals to make the right clinical decision quickly at a reasonable cost.

Dr. Jun Ho Sun co-founded Kryptos Technologies to commercialize discoveries made as an Assistant Project Scientist and Postdoctoral Researcher at UC Berkeley in the lab of Professor of...

Magnetic Insight

Brief Description

Magnetic Insight is developing solutions in Magnetic Particle Imaging (MPI), a ground-breaking technology that will overcome major deficiencies with current clinical and translational research imaging techniques.

Magnetic Insight Inc. was founded by one of the leading research groups in the global field of Magnetic Particle Imaging from UC Berkeley. Developed over the past decade in the research lab of UC Berkeley Bioengineering and Electrical Engineering and Computer Science Professor Steven Conolly, MPI has proven in animal studies to generate high-contrast...

Myo Corps

Brief Description

Measuring muscle mass through analysis of creatinine in urine samples. The company's proprietary D3Creatine dilution method to measure muscle mass, termed the Muscle Assessment Test (MAT), is being used to assess muscle mass in several NIH sponsored cohort studies including the Framingham Heart Study, Women's Health Inititiative, Tobago Longitudinal Aging Study, the Study on Muscle, Mobility, and Aging (SOMMA), and more. The goal is to achieve FDA approval for the MAT as a diagnostic test for muscle mass.

MyoCorps CEO William J. Evans, PhD, is an...

Xip Diagnostics

Brief Description

Xip Diagnostics develops analytical solutions that advance human and animal health at the point of need through in-house product development and industry-leading collaborations.

The company's disposable blood analyzers wirelessly upload lab-quality clinical measurements in minutes, providing blood testing with no hassles, no delays, and no instrument. These devices will be deployed in Emergency Departments (EDs), clinics, and eventually the home.

Xip Diagnostics Founder and CEO Dr. Octavian Florescu spun out the company to commercialize research discoveries...

O.N. Diagnostics, LLC

Brief Description

O.N. Diagnostics was founded by UC Berkeley Professor of Mechanical Engineering Tony M. Keaveny based on biomedical engineering research conducted at UC Berkeley and UC San Francisco. The company's mission is to improve patient outcomes by developing non-invasive and clinically effective diagnostic applications that quantitatively exploit the richness of information in CT scans. The company achieves scientific and technological excellence through rigorous research and validation, combined with the highest industry standards in execution and quality control....

GenEdit, Inc.

Brief Description

GenEdit develops innovative therapies through targeted delivery of genetic medicines. The GenEdit founders share the vision that recent scientific advancements in engineering CRISPR components and delivery vehicles offer a groundbreaking opportunity to develop safe and effective medicines for genetic diseases.

The company's proprietary Polymer nanoparticle can deliver CRISPR protein and gRNA. CRISPR in a protein form has many advantages, delivery has been a challenge limiting its application. To deliver CRISPR protein, encapsulation of CRISPR ribonucleoprotein (RNP...

Nodexus, Inc.

Brief Description

Nodexus is commercializing an integrated, “one-click” platform that is low-cost, compact, and provides a simplified workflow to deliver enriched single cells of interest from a wide variety of samples such as stem cells, transfected cell lines, cultured cell lines, dissociated tissue, and whole blood.

Timeline 2014. Company founded. Inventors

Lydia Sohn, Daniel Yang, George Anwar, James Hack, Karthik Balakrishnan, Matthew Chambers, Matthew Chapman

Marco Medical

Brief Description

Prevention and treatment of Glaucoma, a leading cause of blindness that affects around 80 million people worldwide.

Timeline 2023. Company founded Inventor

Lu Chen

Microbial Medical

Brief Description

Microbial Medical was established to launch novel imaging agents and drugs for diagnosing and treating bacterial and fungal infections, based on a platform technology for chemically linking existing medical compounds with sugars that pathogens consume and human cells reject. The launch products were contrast agents that enable common medical scanners to image infection. The company also planned to produce antibiotics that address antibiotic resistance and have reduced toxicity.

Timeline 2015. Company founded Inventors

Kiyoko Takemiya, Mark Goodman...